Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

EGFR inhibitors can cause yellowish skin eruptions.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Most skin cysts were common types found in unusual body parts, and examining tissue samples is important for accurate diagnosis.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Wnt signaling is crucial for skin wound healing and reducing scars.

Testosterone may slow down wound healing and increase inflammation.